On October 24, 2022 Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, reported that the management team will participate in and attend one-on-one meetings at two investor conferences in November 2022 as follows (Press release, Gracell Biotechnologies, OCT 24, 2022, View Source [SID1234622320]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Credit Suisse 31st Annual Healthcare Conference 2022
One-on-one meetings: Tuesday, November 8, 2022
Location: Rancho Palos Verdes, CA
Jefferies London Healthcare Conference 2022
Fireside Chat: November 15 at 2:40 pm GMT
One-on-one meetings: Tuesday, November 15, 2022
Location: London, UK
A webcast of the fireside chat will be available on the News and Events section of Gracell’s investor website. A replay of the webcast will be available for 30 days following the event.